P1.22. Ventana ALK (D5F3) Immunohistochemistry Improves the Accuracy of Pathologic Assessment after Neoadjuvant ALK-TKIs for ALK-Positive NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Li-Xu Yan
Meta Tag
Speaker Li-Xu Yan
Topic Pathology & Biomarkers: Genetic Biomarkers
Ventana ALK (D5F3) immunohistochemistry
pathological assessment
neoadjuvant ALK-TKIs
ALK-positive non-small cell lung cancer
Guangdong Provincial People's Hospital
morphological changes
tumor cytoplasm
intracytoplasmic mucin
residual viable tumor cells
Powered By